Diabetic Peripheral Neuropathy Market is anticipated to grow with a CAGR of 12% by 2030 attributed to increasing DPN prevalence, and introduction to gene therapies in the pipeline.
Diabetes prevalence has been on a gradual rise globally attributable to a paralleled rise in a sedentary lifestyle, obesity and increased life expectancy. A major cause of kidney failures, heart attacks, damaged nerves, lower limb amputations and blindness, Diabetes took the lives of an estimated 1.6 million people worldwide in 2016, as per the WHO. Moreover, Diabetes was recorded to be the seventh leading cause of deaths.
Diabetes and associated comorbidities, complications and the ...
